Project Grant R01HL183346
Award Date 6/1/26
Completion Date 3/31/31
Dollars Obligated $250K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21205, USA
Similar Awards
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a $248,919 Project Grant effective June 1, 2026 through April 30, 2029 under the Cardiovascular Diseases Research program (CFDA 93.837). This research initiative investigates muscle metabolism and exercise intolerance in patients with heart failure with preserved ejection fraction (HFpEF), the fastest-growing form of heart failure. The project will utilize novel interleaved...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a Project Grant of $638,176 (Award Date: May 1, 2026; Completion Date: February 28, 2029) under the Cardiovascular Diseases Research program (CFDA 93.837). This grant funds basic research investigating thrombospondin-1 (TSP-1), a matricellular protein, as a therapeutic target for treating heart failure with preserved ejection fraction (HFpEF). The research will examine the...
- Federal Project Grant Award Summary Oregon Health & Science University (OHSU) received a $197,160 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025 through July 31, 2028. The award supports a three-year planning project to assess the feasibility, acceptability, and initial effectiveness of the Rural Caregiver Heart Health Education (RICHH) intervention adapted for custodial...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a Project Grant totaling $198,654 under the Cardiovascular Diseases Research program (CFDA 93.837) effective August 1, 2025, through July 31, 2030. This award supports a five-year research initiative investigating the role of diet quality and food insecurity as modifiable factors linking socioeconomic status to Chronic Obstructive Pulmonary Disease (COPD) morbidity and...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a $180,488 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) effective March 1, 2026, through September 15, 2027, to conduct research on severe acute respiratory failure (ARF) following immune checkpoint inhibitor (ICI) therapy. The research will identify clinical and biomarker risk factors associated with ARF in ICI-treated cancer patients and evaluate...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a Project Grant totaling $120,363 under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 18, 2025, through July 31, 2030. This K24 Mid-Career Investigator Award provides resources, training, and protected time to strengthen and expand Dr. Michelle Eakin's mentoring program focused on patient-oriented implementation science in asthma care. The award...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a $514,484 Project Grant (CFDA 93.837: Cardiovascular Diseases Research) on August 24, 2025, for research investigating the role of kynurenine pathway metabolism in pulmonary arterial hypertension (PAH). The research will be conducted through June 30, 2030, at Johns Hopkins' Maryland facilities. The project delivers basic and translational research services focused on...
- Federal Grant Award Summary Dr. Cross's K01 career development grant, funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), totaling $142,870 and spanning September 1, 2025, through August 31, 2029, supports a mixed-methods research initiative examining end-of-life care disparities for adults with heart failure. The project addresses a critical gap in Medicare hospice policy, which was designed for cancer patients and...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Alabama at Birmingham $170,601.00 under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and test a multi-component remote care intervention for rural patients with heart failure. The five-year project, initiated August 1, 2025, and extending through July 31, 2030, addresses the critical health disparity whereby rural populations experience significantly higher...
- Federal Grant Award Summary The National Institute of Nursing Research (NINR), under the Nursing Research Federal Grant Program (CFDA 93.361), awarded Johns Hopkins University a $1.43 million Project Grant effective September 15, 2025, through June 30, 2030, to evaluate the effectiveness of an integrated group postpartum and well-child care model on maternal and child health outcomes. The research addresses critical gaps in maternal and infant health service delivery in low-resource settings...